Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
The ARRplus: a model for renin-dependent and sex-specific aldosterone cut-offs that improves screening for primary aldosteronismSybille Fuld, Jun Yang, Georgiana Constantinescu, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
Elife|July 14, 2023
Succinate mediates inflammation-induced adrenocortical dysfunctionIvona Mateska, Anke Witt, Eman Hagag, et al.
Hypertension (Dallas, Tex. : 1979)|October 19, 2020
Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome ProfilesTwinkle Vohra, Elisabeth Kemter, Na Sun, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Cancers|January 1, 2020
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor OriginJulia Biedermann, Matthias Preussler, Marina Conde, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA InvestigatorsAnne-Paule Gimenez-Roqueplo, Aurore Caumont-Prim, Claire Houzard, et al.
Clinical Chemistry and Laboratory Medicine|January 11, 2024
Report from the HarmoSter study: different LC-MS/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged swordFlaminia Fanelli, Mirko Peitzsch, Stephen Bruce, et al.
Pageof 15